搜索临床试验以:NK细胞输注
总计12240个结果
-
Talaris Therapeutics Inc.Northwestern University主动,不招人
-
Celyad Oncology SANational Heart, Lung, and Blood Institute (NHLBI); Dana-Farber Cancer Institute完全的
-
Makerere UniversityInfectious Diseases Institute, Uganda完全的
-
St. Jude Children's Research HospitalCURE Childhood Cancer, Inc.完全的
-
University Hospital FreiburgGerman Federal Ministry of Education and Research; International Extranodal Lymphoma Study Group...未知
-
Juno Therapeutics, a Subsidiary of Celgene完全的淋巴瘤,B细胞 | 淋巴瘤,大 B 细胞,弥漫性 | 淋巴瘤,非霍奇金 | 淋巴瘤,非霍奇金美国
-
Juno Therapeutics, a Subsidiary of CelgeneBristol-Myers Squibb完全的肿瘤 | 组织学类型的肿瘤 | 淋巴瘤 | 淋巴瘤,B细胞 | 淋巴瘤,大 B 细胞,弥漫性 | 淋巴增生性疾病 | 淋巴系统疾病 | 免疫增生性疾病 | 淋巴瘤,非霍奇金 | 免疫系统紊乱美国
-
Odense University Hospital未知
-
Imperial College LondonCambridge University Hospitals NHS Foundation Trust; University of Edinburgh; University of Manchester 和其他合作者终止
-
National Heart, Lung, and Blood Institute (NHLBI)Loyola University Medical Center (LUMC)招聘中
-
M.D. Anderson Cancer Center主动,不招人
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)完全的
-
Michael Pulsipher, MDSeattle Children's Hospital; Nationwide Children's Hospital邀请报名
-
Wuxi People's HospitalImbioray (Hangzhou) Biomedicine Co., Ltd.招聘中
-
Murdoch Childrens Research InstituteSydney Children's Hospitals Network; Monash Health; Cerebral Palsy Alliance; The Royal Children's... 和其他合作者完全的
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering Institute完全的
-
City of Hope Medical CenterNational Cancer Institute (NCI); California Institute for Regenerative Medicine (CIRM)招聘中
-
XEME Biopharma Inc.National Cancer Institute (NCI)主动,不招人
-
James Baumgartner, MD暂停
-
University of LeicesterUniversity Hospitals, Leicester; Freemasons' Medical Research Funding完全的
-
Dana-Farber Cancer Institute招聘中急性髓性白血病 | 骨髓增生异常综合征 | 白血病 | 白血病,骨髓 | 骨髓增生性疾病 | 骨髓增殖性肿瘤美国
-
Landmark Medical Centre Sdn BhdCytoMed Therapeutics Pte Ltd未知
-
National University Hospital, SingaporeSingapore General Hospital未知
-
University of Kansas Medical CenterIn8bio Inc.招聘中
-
Atara Biotherapeutics不再可用淋巴增生性疾病 | 干细胞移植并发症 | EB 病毒 (EBV) 感染 | EBV+相关淋巴瘤 | EBV+ 相关的移植后淋巴增生性疾病 (EBV+ PTLD) | 爱泼斯坦-巴尔病毒血症 | 淋巴瘤,艾滋病相关 | EB 病毒相关淋巴增生性疾病 (EBV+ LPD) 伴原发性免疫缺陷 (PID) | 平滑肌肉瘤 (LMS) | 鼻咽癌 (NPC) | EB 病毒相关淋巴组织增生性疾病 (EBV+ LPD) 伴获得性免疫缺陷 (AID) | 实体器官移植并发症
-
bluebird bio完全的
-
Chinese PLA General Hospital招聘中